A comprehensive analysis of amino-peptidase N1 protein (APN) from Anopheles culicifacies for epitope design using Immuno-informatics models.

A comprehensive analysis of amino-peptidase N1 protein (APN) from Anopheles culicifacies for epitope design using Immuno-informatics models. Bioinformation. 2019;15(8):600-612 Authors: Jakhar R, Kumar P, Sehrawat N, Gakhar SK Abstract Analysis of the Amino-peptidase N (APN) protein from Anopheles culicifacies as a vector based Transmission Blocking Vaccines (TBV) target has been considered for malaria vaccine development. Short peptides as potential epitopes for B cells and cytotoxic T cells and/or helper T cells were identified using prediction models provided by NetCTL and IEDB servers. Antigenicity determination, allergenicity, immunogenicity, epitope conservancy analysis, atomic interaction with HLA allele specific structure models and population coverage were investigated in this study. The analysis of the target protein helped to identify conserved regions as potential epitopes of APN in various Anopheles species. The T cell epitopes like peptides were further analyzed by using molecular docking to check interactions against the allele specific HLA models. Thus, we report the predicted B cell (VDERYRL) and T cell (RRYLATTQF for HLA class I and LKATFTVSI for HLA class II) epitopes like peptides from APN protein of Anopheles culicifacies (Diptera: Culicidae) for further consideration as vaccine candidates subsequent to in vitro and in vivo analysis. PMID: 31719771 [PubMed]
Source: Bioinformation - Category: Bioinformatics Authors: Tags: Bioinformation Source Type: research

Related Links:

Nature, Published online: 06 December 2019; doi:10.1038/d41586-019-03788-7Piped-in sounds of a healthy reef tempt young fish to re-colonize degraded areas. Plus: The San Andreas and Cascadia earthquake faults might be linked and how to build a better malaria vaccine.
Source: Nature AOP - Category: Research Authors: Source Type: research
In this study, we dissected the response of three TCR γδ cell subsets and mucosal-associated invariant T cells in healthy volunteers immunized with PfSPZ Vaccine and challenged by CHMI using Sanaria PfSPZ Challenge. Using a flow cytometry-based unbiased analysis followed by T cell cloning, several findings were made. Whereas major ex vivo alterations were not detectable after immunization with PfSPZ Vaccine, TCR Vδ2, and mucosal-associated invariant T cells expanded after asexual blood-stage parasitemia induced by CHMI. CHMI, but not vaccination, also induced the activation of TCR Vδ1 and Vδ1-...
Source: Journal of Immunology - Category: Allergy & Immunology Authors: Tags: J Immunol Source Type: research
Despite the extensive endeavours, developing an effective malaria vaccine remains as a great challenge. Apical membrane antigen 1 (AMA-1) located on the merozoite surface of parasites belonging to the genus Plasm...
Source: Malaria Journal - Category: Infectious Diseases Authors: Tags: Research Source Type: research
Plasmodium falciparum malaria is a disease causing high morbidity and mortality rates worldwide, mainly in sub-Saharan Africa. Candidates have been identified for vaccines targeting the parasite’s blood stage; this stage is important in the development of symptoms and clinical complications. However, no vaccine that can directly affect morbidity and mortality rates is currently available. This review analyzes the formulation, methodological design, and results of active clinical trials for merozoite-stage vaccines, regarding their safety profile, immunological response (phase Ia/Ib), and protective efficacy levels (p...
Source: Frontiers in Microbiology - Category: Microbiology Source Type: research
This study aimed at evaluating the antiplasmodial activity of ANI combinations with artesunate (AS) or chloroquine (CQ) against P. falciparum in vitro based on the semiautomated microdilution assay and P. berghei in vivo based on Peters' 4-day test. Data were analysed by linear regression using version 5.5 of Statistica, 2000. From the results, on the one hand, a combination of 1.1 ng/ml AS and 3.3 μg/ml of ANI inhibited 50% growth of W2, while a combination of 0.8 ng/ml of AS and 2.6 μg/ml of ANI inhibited 50% growth of 3D7. On the other hand, a combination of 22 ng/ml CQ and 3.7&t...
Source: Biomed Res - Category: Research Authors: Tags: Biomed Res Int Source Type: research
Conclusions: These results presented evidence of the role of TLR-4/rBCG attachment mechanism in modulating the production of NO and IL-10 and the expression of iNOS in response to our rBCG-based malaria vaccine candidate expressing MSP-1C ofP. falciparum.
Source: The Journal of Infection in Developing Countries - Category: Infectious Diseases Source Type: research
Indian-origin rhesus (InR) are preferred for research, but strict export restrictions continue to limit their use. Chinese-origin rhesus (ChR), although easier to procure, are genetically distinct from InR and...
Source: Malaria Journal - Category: Infectious Diseases Authors: Tags: Research Source Type: research
Nature, Published online: 27 November 2019; doi:10.1038/d41586-019-03639-5As the first vaccine against the malaria parasite begins to roll out, scientists are working on a wide variety of alternatives that they hope will provide more protection.
Source: Nature AOP - Category: Research Authors: Source Type: research
Pneumococcal conjugate vaccine use in children has led to sharp declines in pneumococcal disease among adults and children.
Source: CDC Morbidity and Mortality Weekly Report - Category: American Health Tags: Immunization Immunization Schedules Malaria MMWR Morbidity & Mortality Weekly Report Outbreaks Pneumococcal Conjugate Vaccine for children Salmonella Source Type: news
Re: Musings on malaria morbidity and mortality after the new Mosquirix® vaccine. Ghana Med J. 2019 Sep;53(3):252-253 Authors: Asante KP, Malm K, Darko DM, Koram KA PMID: 31741498 [PubMed - in process]
Source: Ghana Medical Journal - Category: African Health Tags: Ghana Med J Source Type: research
More News: Bioinformatics | Malaria | Malaria Vaccine | Study | Vaccines